Clinical Trial Update: Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intrapleural DNase and tissue plasminogen activator for pediatric empyema has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pleural Empyema

Drugs mentioned

• DTPA (intrapleural DNase and tissue plasminogen activator)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Pleural Empyema | Phase 3 | Status: COMPLETED | Results posted: 2020-04-03